Published • loading... • Updated
AMGEN ANNOUNCES 2026 FOURTH QUARTER DIVIDEND
Amgen’s board approved the payout as the company continues a long record of quarterly dividends to shareholders.
- On Tuesday, October 27, 2026, Amgen's Board of Directors declared a $2.52 per share dividend for the fourth quarter of 2026, reaffirming the company's commitment to shareholder returns.
- Founded more than 45 years ago at its Thousand Oaks, California, headquarters, Amgen helped establish the biotechnology industry and remains at the cutting edge of innovation today.
- Stockholders of record at the close of business on November 20, 2026, will receive payment on December 11, 2026, ensuring timely distribution to eligible investors.
- Amgen, a member of the Dow Jones Industrial Average and Nasdaq-100 Index, develops innovative medicines for cancer, heart disease, inflammatory conditions, and obesity-related diseases.
- Future performance remains subject to risks including geopolitical relations and government actions, according to Amgen's Securities and Exchange Commission filings and forward-looking statements.
Insights by Ground AI
15 Articles
15 Articles
AMGEN ANNOUNCES 2026 FOURTH QUARTER DIVIDEND
THOUSAND OAKS, Calif., Oct. 27, 2026 /PRNewswire/ -- Amgen (NASDAQ: AMGN) today announced that its Board of Directors declared a $2.52 per share dividend for the fourth quarter of 2026. The dividend will be paid on December 11, 2026, to…
·Pennsylvania, United States
Read Full Article
Amgen Inc. (NASDAQ:AMGN) Declares Quarterly Dividend of $2.52
Amgen Inc. (NASDAQ:AMGN – Get Free Report) announced a quarterly dividend on Tuesday, October 27th. Investors of record on Friday, November 20th will be paid a dividend of $2.52 per share by the medical research company on Friday, December 11th. This represents a $10.08 annualized dividend and a yield of 2.2%. The ex-dividend date of […]
Coverage Details
Total News Sources15
Leaning Left0Leaning Right1Center12Last UpdatedBias Distribution92% Center
Bias Distribution
- 92% of the sources are Center
92% Center
C 92%
Factuality
To view factuality data please Upgrade to Premium
